Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma.

Oncol Lett · 2016 · PMC4774472 · PMID 26998059

Europe PMC DOI

hedged sentence

0.0790

closest p · 1.6× alpha

0.0790

boldest claim

The sentences

a weak trendP=0.079so close (0.05 < p ≤ 0.1)

Furthermore, higher nuclear survivin expression showed a weak trend for poorer OS rate (P=0.079), whilst neither cytoplasmic survivin, EGFR nor p16 influenced OS or PFS significantly.

also in 1,404 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.